Satoshi Takakusagi

Effect of 48‐week pemafibrate on non‐alcoholic fatty liver disease with hypertriglyceridemia, as evaluated by the <scp>FibroScan‐</scp>aspartate aminotransferase score

Takeshi Hatanaka, Takashi Kosone, Naoto Saito et al. · JGH Open · 2021 · 34 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Clinical and virological features of acute hepatitis E in Gunma prefecture, Japan between 2004 and 2015

Yuichi Yamazaki, Atsushi Naganuma, Yosuke Arai et al. · Hepatology Research · 2016 · 17 citations

Medicine, Hematology, Infectious Diseases +14

Spontaneous remission of hepatitis B virus reactivation during direct‐acting antiviral agent‐based therapy for chronic hepatitis C

Ken Sato, Takeshi Kobayashi, Yuichi Yamazaki et al. · Hepatology Research · 2017 · 17 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Combination Therapy with Ombitasvir/Paritaprevir/Ritonavir for Dialysis Patients Infected with Hepatitis C Virus: A Prospective Multi-Institutional Study

Ken Sato, Kenichi Hosonuma, Yuichi Yamazaki et al. · The Tohoku Journal of Experimental Medicine · 2017 · 13 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Efficacy of Zinc Acetate Treatment for Patients with Decompensated Liver Cirrhosis Complicated by Hypozincemia

Suguru Horiguchi, Atsushi Naganuma, Yumeo Tateyama et al. · Biological Trace Element Research · 2021 · 11 citations

Medicine, Pharmacology, Pharmacotherapy +11